Parnell Pharmaceuticals Holdings Ltd. (PARNF)

[MaineMan5]

Sleeper with tremendous potential. Revenue growth of 25% to $10.3mm last qtr, substantial improvement in profitability for first half of 2017. Ramping up development of PAR122 and PAR121 rest of year, PAR122 does not require FDA approval process. New contract manufacturing agreement in May 2017 that is a multi-million dollar, multi-year agreement. Turning EBITDA positive in 4th Q. Meetings with FDA and EMA in Oct. on Zydax. If don't need more data, could be approved by year end. Already being used in many countries with millions of doses. Possible human applicability. Manufacturing facility itself valued by company on recent call at approx $50 million ($2.77 share). Not thrilled they voluntarily moved to pink sheets (saves company $6 million year), but has had the desired effect. Upcoming catalysts on drugs and manufacturing. I would encourage everyone to read the detailed latest quarter business results at:

https://finance.yahoo.com/news/parnell-pharmaceuticals-holdings-ltd-announces-143000455.html